Jim Lees

PricewaterhouseCoopers LLP engages in the provision of accounting services. Its services include audit and assurance, accounting advisory, risk assurance, tax management, corporate insolvency, life cycle assessment, forensic services, private equity advisory, and financial reporting valuations. The company is headquartered in London, the United Kingdom.

Porton Biopharma Ltd. is a biopharmaceutical company based in Salisbury, UK. The British company is focused on the development and manufacture of biopharmaceutical products for the treatment of infectious diseases and cancer. Porton Biopharma is committed to delivering high-quality products that meet the needs of patients and healthcare providers. The CEO of the private company is Roger Hinton, who leads a team of experienced professionals dedicated to advancing the company's mission.

Chronos Therapeutics Ltd. manufactures drugs. It pursuing innovative therapeutics for age-related diseases through the joint efforts of experts in medical research, drug discovery and business development. The company was founded in 2009 and is headquartered in Oxford, the United Kingdom.

The Association of the British Pharmaceutical Industry is a non-profit organization, which engages in the research and development of medicines. It focuses on biosciences. The company is headquartered in London, the United Kingdom.

Oncimmune Ltd. provides clinical testing services for cancer detection. The firm develops early cancer detection tests for lung, breast, colorectal, prostate, stomach, pancreatic and ovarian cancers. The company was founded by John F. R. Robertson in 2003 and is headquartered in Nottingham, the United Kingdom.

Pertinax Pharma Ltd. manufactures pharmaceutical products. developing medical, healthcare and veterinary applications of a novel, proprietary long acting formulation of the already widely used antimicrobial drug chlorhexidine. Pertinax Pharma was founded by Michele Barbour in 2015 and is headquartered in Bristol, the United Kingdom.

Beaufort Group Ltd. provides insurance services. The private company is based in London, UK. and has subsidiaries in Norway. The British company was founded by Peter Morgan.

Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY.

Evolution Securities China Ltd. is a brokerage firm based in London, UK. and has subsidiaries in Hong Kong and China. Evolution Securities China Ltd. provides brokerage services. The British company was founded in 2003 by Clive Peter Whiley, who has been the CEO since its inception.

HSBC Bank Plc provides commercial banking and financial services. It operates in four businesses: Retail Banking and Wealth Management, Commercial Banking, Global Banking and Markets, and Global Private Banking. The Retail Banking and Wealth Management business offers personal banking, mortgages, loans, credit cards, savings and investments and insurance services. The Commercial Banking business offers financial products and services to enable them to operate efficiently and meet their business aspirations. The Global Banking and Markets business offers capital financing, transaction and advisory banking services, trade, research, securities services and global liquidity and cash management. The Global Private Banking business offers investment management, incorporating advisory, discretionary and brokerage, private wealth solutions, comprising trusts and estate planning services. The company was founded in 1865 and is headquartered in London, the United Kingdom.

Clinical Insights Ltd. engages in the provision of advisory services to the pharmaceutical industry. The company is headquartered in Milan, Italy.

Sanofi-Aventis Ltd. provides pharmaceutical services. It focuses on cardiovascular medicine, thrombosis, oncology, metabolic disorders and diseases of the central nervous system. The company was founded in December 2004 and is headquartered in Guildford, the United Kingdom.

Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ.

Road Angel Group Ltd. engages in the design and development of global posistioning system based products for the consumer and commercial markets. It also offers safety camera, blackspot locators, Internet connected devices, fleet tracking solutions, personal trackers, and asset tracking solutions. The company was founded by David Clark and Anthony Joseph Eagle on June 25, 2001 and is headquartered in Basford, the United Kingdom.

Part of PAREXEL International Corp., PAREXEL International LLC is a company that operates as a Contract Research Organization (CRO) and provides clinical development services. The company is based in Newton, MA.

Pps Europe Ltd. provides business support services. The private company is based in London, UK.

Part of Plutus Powergen Plc, Cambridge Meditech Ltd. is a company that manufactures wound infection detection products. The company is based in Cambridge, UK. Cambridge Meditech was acquired by Plutus Resources Plc on November 04, 2008 for $0.08 million.

Part of Sienna Biopharmaceuticals, Inc., Creabilis UK Ltd. engages in research and development of biological products. The company is based in Canterbury, UK.

CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany.

Arix Bioscience /Venture Capital/ (Arix Bioscience) is a venture capital subsidiary of Arix Bioscience Plc founded in 2015 by Christopher Thomas Evans, Jonathan M. Peacock and Joseph Anderson. The firm is headquartered in London, United Kingdom with an additional offices in New York.

Part of TiGenix NV, Tigenix SAU is a Spanish company that collects all the research and development of health, agri-food and industrial products from its partners. The company is based in Tres Cantos, Spain. The company has been driving biotechnology in Spain since 1999 and have more than 300 associated companies, startups, and entities. The group Zendal, a 100%% Spanish biopharmaceutical group, includes seven companies focused on manufacturing and commercializing high-value biotechnology products. Tigenix SAU is a member of AseBio, and the membership fees vary depending on the type of entity and the company's age, annual turnover, and equity. The company offers discounts and economic advantages to their members. The AseBio Investor Day is an investment forum that aims to connect the Spanish biotechnology industry with investors.

AstraZeneca UK Ltd. manufactures pharmaceutical products. Its products are used to treat cardiovascular diseases, diabetes, and gastrointestinal infections. The company was founded on November 26, 1998 and is headquartered in London, the United Kingdom.

Hutman Diagnostics AG is a Swiss company that specializes in the development and management of in vitro diagnostics products.

The Royal Society of Medicine provides postgraduate medical education. The Society provides a range of educational activities and opportunities for doctors, dentists and veterinary surgeons, including students, and for allied healthcare professionals. It also promotes an exchange of information and ideas on the science, practice and organization of medicine, both within the health professions and with responsible and informed public opinion. The Society was founded in 1805 and is headquartered in London, the United Kingdom.

Polyneuron Pharmaceuticals AG develops drugs for the treatment of autoimmune disorders. It develops drugs for the treatment of anti-MAG neuropathy disease and multifocal motor neuropathy disease. The firm also develops antibody-catch, a platform technology that enables the development of drugs for highly specific interception of autoimmune disease antibodies and focuses on autoimmune diseases of the peripheral nervous system that involve autoantibodies against carbohydrate epitopes. The company was founded by Andreas J. Steck, Beat Ernst, Pascal Hänggi and Ruben Herrendorffin in 2014 and is headquartered in Basel, Switzerland.